Meeting Overview - The company will hold its 2024 Annual General Meeting (AGM) on May 29, 2025, from 9:15 AM to 3:00 PM, utilizing both on-site and online voting methods [1][2] - The meeting is convened by the company's board of directors and complies with relevant laws and regulations [1][2] Meeting Details - The record date for shareholders to attend the meeting is May 22, 2025 [2] - All registered shareholders can attend and vote, with provisions for proxy voting [2][5] - The physical meeting location is at the company's office in Changsha [2] Agenda Items - The AGM will discuss several proposals, including: - Reappointment of the accounting firm for the 2025 audit [4][6] - Approval of credit limits and guarantees for the company and its subsidiaries for 2025 [4][6] - Election of the sixth board of directors, including both non-independent and independent directors [4][6][12] Voting Procedures - Voting will be conducted through a combination of on-site and online systems, with specific instructions provided for shareholders [8][9] - Shareholders can vote on non-cumulative proposals and allocate votes for cumulative proposals as per their shareholdings [9][12] Registration and Participation - Shareholders must register to attend the meeting, either in person or via mail/fax, by May 26, 2025 [7][8] - Required documentation for registration includes identification and proof of share ownership [7][8] Additional Information - The company will separately count votes from minority investors on significant matters affecting their interests [6] - The meeting will also include a report from independent directors [6]

一、召开会议的基本情况 （一）股东大会届次：2024 年年度股东大会 湖南丽臣实业股份有限公司 关于召开公司 2024 年年度股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：001218 证券简称：丽臣实业 公告编号：2025-017 湖南丽臣实业股份有限公司（以下简称"公司"或"本公司"）于2025年4 月23日在《中国证券报》《上海证券报》《证券时报》及巨潮资讯网 （http://www.cninfo.com.cn）刊登了《湖南丽臣实业股份有限公司关于召开公司 2024年年度股东大会的通知》。本次股东大会现场会议召开时间为2025年5月29 日（星期四）上午10:30。本次股东大会采用现场投票和网络投票相结合的方式召 开，现就本次股东大会提示性公告如下： （二）会议召集人：公司董事会 （三）会议召开的合法、合规性：公司第五届董事会第二十一次会议已于2025 年4月22日审议通过《关于召开公司2024年年度股东大会的议案》，本次股东大 会的召集程序符合《中华人民共和国公司法》《上市公司股东大会规则》《深圳 证券交易所上市公司自 ...

Group 1: Basic Information - The research object is Licheng Industry, belonging to the chemical products industry, and the reception time was May 15, 2025. The company's reception staff included the board secretary, CFO Zheng Gang, and the securities affairs representative Liu Zenghui [17] - The institution participating in the research is Caitong Securities [2] Group 2: Company Business and Performance - The company is based in the fine chemical field, with its main business being the R & D, production, and sales of surfactants and detergents. It has three production bases in Changsha, Shanghai, and Dongguan, with an annual surfactant production capacity of approximately 550,000 tons and an annual detergent production capacity of about 250,000 tons [22] - The anionic surfactant business is the company's main source of revenue and profit. In 2024, the company achieved an operating income of 3.377 billion yuan from surfactant products, a year - on - year increase of 12.68%, accounting for 92.23% of the company's operating income. The production and sales volume of the company's main surfactant products ranked among the top two in the country in 2024 [23] Group 3: Dividend Policy - In 2024, the company's profit distribution plan proposed to distribute cash dividends of 5.10 yuan per 10 shares (tax - included) based on the total share capital of 130,178,260 shares at the end of 2024, totaling 66,390,912.60 yuan. The remaining undistributed profits will be carried forward to the next year [25] - The company will formulate its profit distribution plan in accordance with the "Future Three - Year (2024 - 2026) Shareholder Return Plan" [26] Group 4: Incentive Expenses - According to the company's 2023 restricted stock incentive plan (draft revised version), the company's share - based payment expense amortization in 2024 was 33.17 million yuan, with management expenses accounting for 68.03% and sales expenses accounting for 25.09% [27] Group 5: Project Progress - The first phase of the 250,000 - ton new green surfactant production base and headquarters construction project of Shanghai Aowei entered the trial production stage in early May 2024. The second phase's 57,500 - ton new green surfactant production lines entered the trial production stage in late February and early April 2025 [28]

Group 1: Company Overview - The company operates in the fine chemical sector, focusing on the research, production, and sales of surfactants and cleaning products, with production bases in Changsha, Shanghai, and Dongguan [1] - The annual production capacity for surfactants is approximately 550,000 tons, while the capacity for cleaning products is around 250,000 tons [1] Group 2: Financial Performance - In 2024, the company achieved a revenue of CNY 3.377 billion from surfactant products, marking a 12.68% increase compared to the previous year, accounting for 92.23% of total revenue [2] - The company has maintained a dividend payout ratio of 60% over the past three years, with a proposed cash dividend of CNY 5.10 per 10 shares for 2024, totaling CNY 66,390,912.60 [3] Group 3: Shareholder Returns and Incentives - The company has established a three-year shareholder return plan (2024-2026) to ensure stable and reasonable returns for investors [3] - In 2024, the estimated share-based payment expense is CNY 33.17 million, with management expenses accounting for 68.03% and sales expenses for 25.09% [4] Group 4: Project Updates - The Shanghai Aowei 250,000 tons new green surfactant production base has entered trial production as of early May 2024, with full production expected to take some time [5] - The second phase of the Shanghai project includes a production line with an annual capacity of 57,500 tons, which is also in trial production as of early April 2025 [5]

Core Viewpoint - Lichen Industrial (001218) announced an earnings briefing on May 8, 2025, highlighting its production capacity, customer advantages, and future development plans [1]. Group 1: Production Capacity - The company has three production bases in Changsha, Shanghai, and Dongguan, with an annual production capacity of approximately 550,000 tons for surfactants and 250,000 tons for cleaning products [2]. - The company is currently in the trial production phase of a new project with an annual capacity of 75,000 tons for new green surfactants, which began trial production in early 2025 [2][4]. Group 2: Customer Advantages - The company has established long-term strategic partnerships with major clients such as Procter & Gamble, Blue Moon, and Amway, benefiting from its geographical advantages and stable product quality [2]. - The company’s surfactant products are recognized in the industry, with a strong reputation among well-known daily chemical enterprises [2]. Group 3: Market Trends - The cleaning products market is experiencing positive growth due to increased consumer awareness of hygiene and health, supported by government policies and rising demand for green and intelligent products [2]. - The domestic daily chemical industry benefits from a large rigid consumer base in China [2]. Group 4: R&D and Innovation - The company increased its R&D expenses by 67%, focusing on optimizing liquid amino acid surfactant processes and developing low-freezing-point fatty alcohol ether sulfate [2]. - The company aims to enhance its product technology and variety over the next three years, with plans to strengthen its production capacity and market share [4]. Group 5: Financial Performance - In Q1 2025, the company reported a main revenue of 1.055 billion yuan, a year-on-year increase of 25.83%, while net profit attributable to shareholders decreased by 14.9% [5]. - The company achieved an operating income of 3.649 billion yuan in 2024, up 12.31% from the previous year, driven by increased production capacity and rising raw material prices [3][5]. Group 6: Future Development Plans - The company plans to enhance its surfactant product series and expand its customer base, aiming to establish its Shanghai base as a research and innovation hub and its Guangdong base as a smart manufacturing lighthouse [4]. - The company will continue to focus on innovation and modern management to maintain and increase its market share in the competitive surfactant market [4].

Production Capacity and Client Advantages - The company has three production bases in Changsha, Shanghai, and Dongguan, with an annual production capacity of approximately 550,000 tons for surfactants and 250,000 tons for cleaning products [2][3] - The company has established long-term strategic partnerships with major clients such as Procter & Gamble, Blue Moon, and Colgate, benefiting from stable product quality and location advantages [2][3] Product Applications and Industry Position - The surfactant products include AES, LAS, K12, ammonium salts, AOS, and amino acid types, primarily used in daily detergents, cosmetics, personal care products, and agricultural aids, ranking among the top two in the industry for production and sales in 2024 [3][4] - The company leverages its extensive experience in the cleaning products sector to enhance product quality and customer loyalty through integrated supply chain advantages [3][4] Market Trends and R&D Investments - The cleaning industry is experiencing growth due to increased consumer awareness of hygiene and government support for green products, with a notable rise in demand for home cleaning products [4][5] - R&D expenses increased by 11.67%, focusing on optimizing liquid amino acid surfactant processes and developing low-freezing-point fatty alcohol ether sulfates [4][5] Environmental Initiatives - The company is committed to green development, having passed ISO certifications for greenhouse gas emissions and product carbon footprints, and is recognized as a "National Green Factory" [5][6] Financial Performance and Future Plans - In 2024, the company achieved a revenue of 3.649 billion yuan, reflecting a growth of 12.31% due to increased production capacity and rising raw material prices [6][7] - Future plans include expanding surfactant production, enhancing product technology, and establishing the Guangdong base as a key low-carbon supply chain factory [6][7] Competitive Strategy - The company aims to maintain and enhance market share through innovation, cost leadership, and brand development, focusing on high-quality growth and expanding into high-end daily chemicals and biopharmaceuticals [7]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001218 证券简称：丽臣实业 公告编号：2025-016 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ （二） 非经常性损益项目和金额 √适用 □不适用 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经审计 单位：元 ■ 其他符合非经常性损益定义的损益项目的具体情况 □适用 √不适用 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性损益项目界 定为经常性损益项目的情况说明 □适用 √不适用 公司不存在将《公开发行证券的公司信息披露解释性公告 ...

湖南丽臣实业股份有限公司监事会 关于 2025 年第一季度报告的审核意见 根据《中华人民共和国公司法》《中华人民共和国证券法》以及中国证监会、 深圳证券交易所的有关规定，湖南丽臣实业股份有限公司（以下简称"公司"） 第五届监事会第二十一次会议于 2025 年 4 月 29 日在公司会议室以现场方式召开， 与会监事对公司 2025 年第一季度报告进行了认真的审核，发表审核意见如下： 经审核，公司监事会成员一致认为，公司董事会编制和审议公司《2025 年 第一季度报告》的程序符合法律、行政法规和中国证监会及深圳证券交易所的有 关规定，报告内容真实、准确、完整地反映了公司的实际情况，不存在任何虚假 记载、误导性陈述或者重大遗漏。 湖南丽臣实业股份有限公司监事会 2025 年 4 月 29 日 ...

Financial Performance - The company's revenue for Q1 2025 reached ¥1,054,889,511.23, representing a 25.83% increase compared to ¥838,351,240.61 in the same period last year[5] - Net profit attributable to shareholders decreased by 14.90% to ¥27,656,536.17 from ¥32,498,857.74 year-on-year[5] - Basic and diluted earnings per share fell by 19.23% to ¥0.21 from ¥0.26 in the same quarter last year[5] - Total operating revenue for the current period reached ¥1,054,889,511.23, an increase of 25.8% compared to ¥838,351,240.61 in the previous period[20] - Net profit for the current period was ¥27,656,536.17, a decrease of 14.2% from ¥32,498,857.74 in the previous period[21] Cash Flow - The net cash flow from operating activities turned negative at -¥9,873,532.55, a decline of 112.61% from ¥78,292,781.16 in the previous year[5] - Cash flow from operating activities showed a net outflow of ¥9,873,532.55, compared to a net inflow of ¥78,292,781.16 in the previous period[24] - The company incurred a net cash outflow from investment activities of ¥161,688,600.04, compared to a net outflow of ¥116,303,534.83 in the previous period[24] - The company reported a total cash inflow from investment activities of ¥141,367,445.36, compared to ¥78,019.98 in the last period[24] Assets and Liabilities - The total assets at the end of Q1 2025 were ¥2,898,212,721.52, a 1.20% increase from ¥2,863,914,472.60 at the end of 2024[5] - Current assets total 1,639,338,299.36 RMB, down from 1,694,170,761.50 RMB at the beginning of the period[18] - Cash and cash equivalents decreased to 452,322,045.73 RMB from 662,540,491.85 RMB[18] - Total liabilities stand at 659,160,909.37 RMB, slightly up from 658,427,256.73 RMB[19] - The company's equity attributable to shareholders is 2,239,051,812.15 RMB, an increase from 2,205,487,215.87 RMB[19] Shareholder Information - Total number of common shareholders at the end of the reporting period is 14,349[15] - The largest shareholder, Jia Qizheng, holds 16.78% of shares, totaling 21,840,000 shares[15] - The number of shares held by the top ten shareholders includes significant stakes from Jia Qizheng, Hou Bingyang, and Sun Jianxiong, each holding over 4%[15][16] - The company has no preferred shareholders or significant changes in the top ten shareholders due to margin trading activities[17] Research and Development - Research and development expenses increased by 33.55% to ¥40,180,228.92 compared to ¥30,086,789.00 in Q1 2024, indicating a focus on innovation[11] - Research and development expenses increased to ¥40,180,228.92, up 33.5% from ¥30,086,789.00 in the last period[20] Investment Income - The company reported a significant increase in trading financial assets by 118.98% to ¥175,735,600.99, attributed to the investment of idle funds[10] - The company experienced a 424.68% increase in investment income to ¥366,754.40, driven by returns from wealth management products[12] - The company received tax refunds amounting to ¥20,503,899.70, compared to ¥14,079,247.57 in the last period[24]

Core Viewpoint - The company has proposed a profit distribution plan for the year 2024, which includes a cash dividend of RMB 5.10 per 10 shares, amounting to a total cash dividend of RMB 66,390,912.60, subject to approval at the upcoming shareholders' meeting [2][3][4]. Group 1: Profit Distribution Plan - The profit distribution plan is based on the 2024 fiscal year, with a net profit attributable to shareholders of RMB 109,117,424.41, after accounting for statutory surplus reserves and previous distributions [5]. - The total distributable profit for shareholders is determined to be RMB 110,592,543.29, based on the lower of the consolidated and parent company financial statements [5][6]. - The company plans to distribute cash dividends without issuing new shares or using reserves for capital increase, adhering to the guidelines from the China Securities Regulatory Commission [6][10]. Group 2: Approval Process - The profit distribution proposal was approved by the company's board and supervisory committee and will be submitted for approval at the 2024 annual shareholders' meeting [4][11]. - The proposal is compliant with relevant laws and regulations, ensuring it does not harm the interests of shareholders, particularly minority shareholders [11][12]. Group 3: Cash Dividend Justification - The cash dividend plan is justified by the company's operating performance and cash flow, aligning with its established profit distribution policy [10][13]. - The cumulative cash dividends over the last three years exceed 30% of the average annual net profit, indicating a stable return to shareholders [9].